Sivik Global Healthcare’s Grifois GRFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-62,843
Closed -$576K – 42
2023
Q2
$576K Buy
+62,843
New +$519K 0.13% 42
2022
Q3
– Sell
-100,000
Closed -$1.19M – 43
2022
Q2
$1.19M Sell
100,000
-100,000
-50% -$1.19M 0.68% 38
2022
Q1
$2.34M Buy
+200,000
New +$2.3M 0.96% 44
2021
Q4
– Sell
-200,000
Closed -$2.92M – 50
2021
Q3
$2.92M Buy
+200,000
New +$3.03M 0.7% 41
2021
Q1
– Sell
-250,000
Closed -$4.61M – 52
2020
Q4
$4.61M Buy
+250,000
New +$4.63M 1.88% 31
2020
Q2
– Sell
-175,000
Closed -$3.52M – 56
2020
Q1
$3.52M Sell
175,000
-100,000
-36% -$2.24M 1.39% 33
2019
Q4
$6.41M Sell
275,000
-20,000
-7% -$436K 2.38% 19
2019
Q3
$5.91M Buy
295,000
+194,980
+195% +$4.18M 2.98% 13
2019
Q2
$2.11M Buy
+100,020
New +$1.91M 0.51% 52
2014
Q3
– Sell
-80,000
Closed -$1.76M – 75
2014
Q2
$1.76M Buy
+80,000
New +$1.67M 0.89% 48

Other funds holding GRFS

Sivik Global Healthcare's GRFS Position: Q3 2023 in Review

Sivik Global Healthcare sold out of Grifois (GRFS) in Q3 2023, closing a stake of 62,843 shares — an estimated $576K sold.

Sivik Global Healthcare first reported a position in GRFS in Q2 2014 and held it in 10 quarters. The position peaked at $6.41M in Q4 2019. 132 funds tracked by Wall St. Rank hold GRFS as of Q3 2023.

  • Sivik Global Healthcare reported no remaining Grifois position as of Q3 2023 after selling out during the quarter.
  • Sivik Global Healthcare sold 62,843 Grifois shares in Q3 2023, an estimated $576K.
  • Sivik Global Healthcare first reported a position in Grifois in Q2 2014 and held it in 10 quarters.
  • Sivik Global Healthcare's Grifois position peaked at $6.41M in Q4 2019.
  • 132 funds tracked by Wall St. Rank held Grifois as of Q3 2023.

Based on Sivik Global Healthcare's 13F filing for Q3 2023, filed 7 Nov 2023.